InvestorsHub Logo
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

Re: jerrydylan post# 24288

Friday, 03/13/2009 4:27:10 PM

Friday, March 13, 2009 4:27:10 PM

Post# of 51850
Well, the Merck deal certainly muddies Schering-Plough's focus on relatively small matters, and their interest in making announcements. The people within SP who were most connected to those trials (who used to work for Organon), having survived one merger, may be preoccupied with whether they will survive this one, or be included in the 16,000 jobs to be culled. It doesn't mean everything has ground to a complete halt, or that any and all licensing activities are frozen, but it would be human nature for those people to have their attention diverted.

NeuroInvestment

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News